Daniel T. Scavilla - Nov 21, 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Nov 21, 2024
Transactions value $
-$5,375,100
Form type
4
Date filed
11/25/2024, 04:29 PM
Previous filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $2.19M +50K $43.77 50K Nov 21, 2024 Direct
transaction GMED Class A Common Stock Options Exercise $3.49M +80K +160% $43.58 130K Nov 21, 2024 Direct
transaction GMED Class A Common Stock Sale -$11.1M -130K -100% $85.00 0 Nov 21, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -50K -100% $0.00 0 Nov 21, 2024 Class A Common Stock 50K $43.77 Direct F2
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -80K -100% $0.00 0 Nov 21, 2024 Class A Common Stock 80K $43.58 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person.
F2 These options were granted on January 22, 2018 and are fully vested.
F3 These options were granted on January 22, 2019 and are fully vested.